| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gautami S Patel, Idan Grossmann, Kevin Rodriguez, Mridul Soni, Pranay K Joshi, Saawan C Patel, Devarashetty Shreya, Diana I Zamora, Ibrahim Sang. Acromegaly and the Colon: Scoping Beyond the Pituitary. Cureus. vol 13. issue 11. 2022-01-06. PMID:34987906. |
acromegaly is a complex endocrinological disorder commonly caused by hypersecretion of growth hormone (gh) typically due to pituitary gland tumors. |
2022-01-06 |
2023-08-13 |
Not clear |
| Elijah J Horesh, Jérémy Chéret, Ralf Pau. Growth Hormone and the Human Hair Follicle. International journal of molecular sciences. vol 22. issue 24. 2021-12-24. PMID:34948002. |
acromegaly, or gh excess, is associated with hypertrichosis, excessive androgen-independent growth of body hair, and hirsutism in females, while dysfunctional gh receptor-mediated signaling (laron syndrome) is associated with alopecia and prominent hf defects. |
2021-12-24 |
2023-08-13 |
human |
| Quanya Sun, Xiaoqing Li, Peili Chen, Lili Chen, Xiaolong Zha. The Beta-Cell Function and Glucose Profile of Newly Diagnosed Acromegalic Patients with Normal Glucose Tolerance. International journal of endocrinology. vol 2021. 2021-12-17. PMID:34917145. |
untreated acromegaly is a nature model for unveiling the diabetogenic effects of gh. |
2021-12-17 |
2023-08-13 |
Not clear |
| Sajjad Ali Khan, Nanik Ram, Muhammad Qamar Masood, Najmul Isla. Prevalence of Comorbidities among Patients with Acromegaly. Pakistan journal of medical sciences. vol 37. issue 7. 2021-12-16. PMID:34912391. |
acromegaly is a chronic disorder resulting from excessive secretion of growth hormone and (gh) and insulin-like growth factor 1 (igf-1) and is associated with several comorbidities. |
2021-12-16 |
2023-08-13 |
Not clear |
| Qusay Baqer Alzajaji, Haider A Alidrisi, Abbas A Mansou. Correlation Between Clinical and Biochemical Markers in Patients With Acromegaly on Different Modalities of Treatment. Cureus. vol 13. issue 11. 2021-12-15. PMID:34909342. |
background acromegaly is a disabling disease caused by growth hormone (gh) over-secretion, associated with increased morbidity and mortality through different metabolic and somatic consequences involving soft tissue, acral overgrowth, and skin thickening, which will lead to different clinical manifestations. |
2021-12-15 |
2023-08-13 |
Not clear |
| Yi Yuen Wang, Mueez Waqar, Ahmed Abou-Zeid, Tara Kearney, Carmela Caputo, Julian Davis, Peter Trainer, Claire Higham, Federico Roncaroli, Kanna K Gnanalingha. Value of Early Post-Operative Growth Hormone Testing in Predicting Long-Term Remission and Residual Disease after Transsphenoidal Surgery for Acromegaly. Neuroendocrinology. 2021-12-14. PMID:34052822. |
we studied the value of early post-operative growth hormone (gh) level as a predictor of outcome and to guide early surgical re-exploration for residual disease in patients with acromegaly. |
2021-12-14 |
2023-08-15 |
Not clear |
| R Selvinaz Erol, Semra Tiryaki, Esra Çil Şen, F Yener Öztürk, M Masum Canat, Duygu Yıldız, Adnan Batman, Dilek Güven, Yüksel Altuntas, Elçin Süren, M Kazim Ero. Alteration in choroidal microvasculature determined by optical coherence tomography angiography in patients with acromegaly. Photodiagnosis and photodynamic therapy. vol 36. 2021-12-08. PMID:34673271. |
we aimed to investigate the retinal layers and macular capillary structure using optical coherence tomography angiography (octa) with acromegaly patients and determine the relationship between octa parameters and disease duration, growth hormone (gh) and insuline growth factor (igf - 1) levels. |
2021-12-08 |
2023-08-13 |
Not clear |
| Tyler Cardinal, Casey Collet, Michelle Wedemeyer, Peter A Singer, Martin Weiss, Gabriel Zada, John D Carmichae. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly. Frontiers in endocrinology. vol 12. 2021-12-07. PMID:34867787. |
postoperative gh and degree of reduction in igf-1 predicts postoperative hormonal remission in acromegaly. |
2021-12-07 |
2023-08-13 |
Not clear |
| Tyler Cardinal, Casey Collet, Michelle Wedemeyer, Peter A Singer, Martin Weiss, Gabriel Zada, John D Carmichae. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly. Frontiers in endocrinology. vol 12. 2021-12-07. PMID:34867787. |
determine predictive factors for long-term remission of acromegaly after transsphenoidal resection of growth hormone (gh)-secreting pituitary adenomas. |
2021-12-07 |
2023-08-13 |
Not clear |
| Merel van der Meulen, Amir H Zamanipoor Najafabadi, Leonie H A Broersen, Jan W Schoones, Alberto M Pereira, Wouter R van Furth, Kim M J A Claessen, Nienke R Biermas. State of the art of patient-reported outcomes in acromegaly or GH deficiency: a systematic review and meta-analysis. The Journal of clinical endocrinology and metabolism. 2021-12-06. PMID:34871425. |
state of the art of patient-reported outcomes in acromegaly or gh deficiency: a systematic review and meta-analysis. |
2021-12-06 |
2023-08-13 |
Not clear |
| Hiroyuki Iida, Tatsuya Komagata, Hirotaka Tanaka, Ryusuke Nagasawa, Takuya Nishio, Tomoyuki Shono, Junsaku Kitagawa, Ken-Ichi Ogawara, Koji Shinozaki, Akiteru Seki, Mark Bruce, Tomoya Ohn. Novel Platform for Predicting Drug Effects in Patients with Acromegaly: Translational Exposure-Response Evaluation of Growth Hormone-Inhibitory Effect of Octreotide after Growth Hormone-Releasing Hormone Stimulation. The Journal of pharmacology and experimental therapeutics. vol 379. issue 3. 2021-12-03. PMID:34599040. |
we evaluated the e-r relationship of the growth hormone (gh)-inhibitory effect of the somatostatin analog octreotide under growth hormone-releasing hormone + arginine stimulation in healthy participants and compared the results with historical data for patients with acromegaly. |
2021-12-03 |
2023-08-13 |
human |
| Poranee Ganokroj, Sarat Sunthornyothin, Rungsak Siwanuwatn, Kraisri Chantra, Patinut Buranasupkajorn, Sompongse Suwanwalaikorn, Thiti Snabboo. Clinical characteristics and treatment outcomes in acromegaly, a retrospective single-center case series from Thailand. The Pan African medical journal. vol 40. 2021-11-30. PMID:34795812. |
acromegaly, an overproduction of growth hormone (gh), is associated with high rate of morbidity and mortality particularly in case of delayed in diagnosis and treatment. |
2021-11-30 |
2023-08-13 |
Not clear |
| Brian P Hanley, Keith Brewer, George Churc. Results of a 5 year N-of-1 GHRH gene therapy experiment. Rejuvenation research. 2021-11-29. PMID:34841890. |
igf-1 levels were little affected, nor were gh test results, showing no indications of acromegaly for the hormone homolog used. |
2021-11-29 |
2023-08-13 |
human |
| T L C Wolters, C D C C van der Heijden, O Pinzariu, B T P Hijmans-Kersten, C Jacobs, C Kaffa, A Hoischen, M G Netea, J W A Smit, D H J Thijssen, C E Georgescu, N P Riksen, R T Netea-Maie. The association between treatment and systemic inflammation in acromegaly. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 57-58. 2021-11-18. PMID:33964727. |
acromegaly is characterized by an excess of growth hormone (gh) and insulin like growth-factor 1 (igf1), and it is strongly associated with cardiovascular diseases (cvd). |
2021-11-18 |
2023-08-13 |
Not clear |
| Burak Mergen, Ceyhun Arici, Osman Kizilkilic, Necmettin Tanriover, Pinar Kadiogl. Lacrimal gland enlargement and tear film changes in acromegaly patients: A controlled study. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. vol 59. 2021-11-18. PMID:34023594. |
evaluation of the lacrimal gland volume (lgv) and its correlation with tear film functions, serum growth hormone (gh) and insulin-like growth factor-1 (igf-1) levels in acromegaly patients compared to a control group was aimed. |
2021-11-18 |
2023-08-13 |
Not clear |
| Daisuke Otani, Takaaki Murakami, Takeshi Matsubara, Masato Hojo, Takuro Nakae, Koki Moriyoshi, Akihiro Yasoda, Ryota Usui, Hisato Tatsuoka, Masahito Ogura, Nobuya Inagaki, Taizou Yamamot. Acromegaly accompanied by diabetes mellitus and polycystic kidney disease. Endocrine journal. vol 68. issue 1. 2021-11-17. PMID:32814722. |
acromegaly is characterized by autonomous excessive growth hormone (gh) secretion, generally due to gh-producing pituitary adenoma, and is associated with various systemic comorbidities including diabetes mellitus. |
2021-11-17 |
2023-08-13 |
Not clear |
| Daisuke Otani, Takaaki Murakami, Takeshi Matsubara, Masato Hojo, Takuro Nakae, Koki Moriyoshi, Akihiro Yasoda, Ryota Usui, Hisato Tatsuoka, Masahito Ogura, Nobuya Inagaki, Taizou Yamamot. Acromegaly accompanied by diabetes mellitus and polycystic kidney disease. Endocrine journal. vol 68. issue 1. 2021-11-17. PMID:32814722. |
while possible renal effects of excessive gh exposure have been a current issue in experimental medicine, only five cases of coexisting acromegaly and pkd have been reported previously, and little is known regarding the influence of acromegaly on renal disease. |
2021-11-17 |
2023-08-13 |
Not clear |
| Anna Elisabet Borgen, Anne Birgitte Dyhre Bugge, Eva Løbner Lund, Jytte Banne. Undiagnosed acromegaly as an underlying cause of sudden death. Forensic science, medicine, and pathology. vol 17. issue 2. 2021-11-08. PMID:33847875. |
recent studies have shown that the increased mortality seen in acromegaly patients can be reversed with modern treatment aimed at normalizing gh and igf-i levels. |
2021-11-08 |
2023-08-13 |
Not clear |
| Marcus Quinkler, David Petroff, Ulrich J Knappe, Jochen Schopohl, Anke Tönjes, Sebastian M Schmi. Medical Therapy of Acromegaly in Germany 2019 - Data from the German Acromegaly Registry. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. vol 129. issue 3. 2021-11-05. PMID:32604431. |
acromegaly is a rare disease caused by excessive growth hormone (gh) secretion from pituitary adenomas in most cases. |
2021-11-05 |
2023-08-13 |
Not clear |
| Pamela U Freda, Jeffrey N Bruce, Carlos Reyes-Vidal, Simran Singh, Yessica DeLeon, Zhezhen Jin, Alexander G Khandji, Serge Cremers, Kalmon D Pos. Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly. Pituitary. vol 24. issue 2. 2021-11-04. PMID:33124000. |
prognostic value of nadir gh levels for long-term biochemical remission or recurrence in surgically treated acromegaly. |
2021-11-04 |
2023-08-13 |
Not clear |